InspireMD/$NSPR
1D1W1MYTD1Y5YMAX
About InspireMD
InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.
- Ticker
- $NSPR
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 127
- Headquarters
- Miami, United States
- Website
- www.inspiremd.com
InspireMD Metrics
BasicAdvanced
$43M
-
-$0.65
0.77
-
Price and volume
Market cap
$43M
Beta
0.77
52-week high
$2.57
52-week low
$0.63
Average daily volume
83K
Financial strength
Current ratio
3.797
Quick ratio
3.403
Long term debt to equity
6.249
Total debt to equity
9.6
Profitability
EBITDA (TTM)
-52.98
Gross margin (TTM)
18.05%
Net profit margin (TTM)
-484.11%
Operating margin (TTM)
-494.03%
Effective tax rate (TTM)
-0.12%
Revenue per employee (TTM)
$90,000
Management effectiveness
Return on assets (TTM)
-85.85%
Return on equity (TTM)
-202.81%
Valuation
Price to revenue (TTM)
6.892
Price to book
1.37
Price to tangible book (TTM)
1.37
Price to free cash flow (TTM)
-1.76
Free cash flow yield (TTM)
-56.83%
Free cash flow per share (TTM)
-0.523
Growth
Revenue change (TTM)
53.42%
Earnings per share change (TTM)
-22.44%
3-year revenue growth (CAGR)
26.58%
10-year revenue growth (CAGR)
17.02%
3-year earnings per share growth (CAGR)
-26.96%
What the Analysts think about InspireMD
Analyst ratings (Buy, Hold, Sell) for InspireMD stock.
InspireMD Financial Performance
Revenues and expenses
InspireMD Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.